OHR Pharmaceutical Inc. Daily Stock Analysis

Daily Stock Analysis, OHRP, OHR Pharmaceutical Inc, priceseries

OHR Pharmaceutical Inc. Daily Stock Analysis
Stock Information
Open
4.81
Close
4.89
High
5.12
Low
4.80
Previous Close
4.93
Daily Price Gain
-0.04
YTD High
400.00
YTD High Date
Mar 17, 2014
YTD Low
1.58
YTD Low Date
Dec 31, 2018
YTD Price Change
-158.11
YTD Gain
-97.00%
52 Week High
400.00
52 Week High Date
Mar 17, 2014
52 Week Low
1.58
52 Week Low Date
Dec 31, 2018
52 Week Price Change
-158.11
52 Week Gain
-97.00%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Apr 12. 2017
15.20
Apr 18. 2017
16.00
3 Trading Days
5.27%
Link
LONG
Aug 18. 2017
12.80
Sep 6. 2017
14.54
12 Trading Days
13.57%
Link
LONG
Nov 17. 2017
13.80
Nov 28. 2017
15.05
6 Trading Days
9.06%
Link
LONG
Jun 11. 2018
4.33
Jun 14. 2018
4.55
3 Trading Days
5.01%
Link
LONG
Aug 28. 2018
3.60
Sep 6. 2018
3.83
6 Trading Days
6.41%
Link
LONG
Oct 1. 2018
3.83
Oct 4. 2018
4.17
3 Trading Days
8.82%
Link
LONG
Jan 2. 2019
2.20
Jan 8. 2019
2.45
4 Trading Days
11.34%
Link
LONG
Mar 6. 2019
3.10
Mar 7. 2019
3.71
1 Trading Days
19.67%
Link
LONG
Apr 29. 2019
2.29
May 10. 2019
2.62
9 Trading Days
14.32%
Link
LONG
May 17. 2019
2.70
Jun 5. 2019
2.97
12 Trading Days
9.90%
Link
LONG
Jun 11. 2019
3.13
Jun 25. 2019
3.60
10 Trading Days
14.98%
Link
LONG
Jul 12. 2019
5.39
Jul 15. 2019
5.81
1 Trading Days
7.79%
Link
LONG
Jul 30. 2019
4.48
Aug 14. 2019
4.86
11 Trading Days
8.44%
Link
Company Information
Stock Symbol
OHRP
Exchange
NasdaqCM
Company URL
http://www.ohrpharmaceutical.com
Company Phone
(212) 682-8452
CEO
Ira A. Greenstein
Headquarters
New York
Business Address
800 THIRD AVENUE, 11TH FLOOR, NEW YORK, NY 10022
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001173281
About

Ohr Pharmaceutical, Inc. is a pharmaceutical company, which focuses on the development of novel pharmaceuticals for the treatment of serious and unmet medical needs. Its products include Squalamine and Trodusquemine. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY.

Description

OHR Pharmaceutical, Inc., a pharmaceutical company, focuses on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its lead clinical program is topical Squalamine, a small molecule anti-angiogenic drug, which could provide a non-invasive therapy to enhance vision outcomes. The company is evaluating Squalamine, which completed Phase II clinical trials for the treatment of retinal diseases, including wet-AMD, proliferative diabetic retinopathy, and retinal vein occlusion. Its preclinical pipeline of sustained release programs include sustained release formulations of small molecule and protein therapeutics for the treatment of ocular diseases, such as glaucoma, steroid induced glaucoma, ocular allergy, and retinal disease. OHR Pharmaceutical, Inc. is headquartered in New York, New York.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading